2
Clinical Trials associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)Phase IIa Multicenter Clinical Trial to Determine the Feasibility and Safety of the Use of Adipose-derived Mesenchymal Stem Cells (ASC) in the Treatment of Patients With Cicatricial Conjunctivitis Associated With Lyell's Syndrome, Stevens-Johnson Syndrome and Pemphigoid of the Mucous Membranes With Ocular Involvement.
A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC) in the treatment of cicatricial conjunctivitis associated with Lyell's syndrome, Stevens-Johnson's syndrome and mucous membrane pemphigoid with ocular involvement
Assessment of Efficacy and Safety of the allogeneic adipose derived mesenchymal stem cells along with platelet rich fibrin in 24 patients with perianal fistulas: a phase 1 and 2 pilot randomized, single blinded trial
100 Clinical Results associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
100 Translational Medicine associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
100 Patents (Medical) associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
100 Deals associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)